• News

    Are you our new Virtual Network Support Manager?

    COST has made it possible for us to appoint a Virtual Network Support manager to help us in delivering digital content to our participants. This new voluntary role will be in charge of creating a virtual network strategy, coordinating the calls for expression of interest for the new Virtual Mobility Grants, and for creating a report of virtual networking activity undertaken by EuroPMP as an Action. The person who takes on this role will be required to: Prepare and distribute a detailed virtual networking strategy for the entire Action Support planning, preparation for and execution of collaborative activities including online and/or blended meetings Support the selection of hosts for virtual…

  • Events,  News

    Upcoming talks

    Due to the COVID-19 crisis, meetings of the EuroPMP COST Action have had to be postponed. In order to continue the work of the Action, and to help all our members get to know the work that other researchers are focusing on across Europe and around the world, EuroPMP will be offering short (~1 hour) lunchtime seminars on the Zoom platform once per month beginning in September. Links to join the meeting will be sent to members via email before the seminar date. All talks take place at 2pm on the stated date. The next talk will be on the 18th June 2021, and will be presented by Dr Emel…

  • News

    The Effects of COVID-19 on PMP Services Around Europe

    Around the world, the COVID-19 epidemic has been hitting our health care systems very hard. Intensive care units have been inundated with patients requiring careful, around-the-clock care. Physicians have been transferred from their normal duties to hastily set up critical care wards within their districts to try to treat the vast numbers of affected patients. Nurses have been sent out to test patients in temporary drive-up clinics, and biologists and lab workers have had their normal duties re-directed to include testing the enormous numbers of patient samples incoming daily from worried patients. We have heard much about the effects on primary care physicians and clinical specialists, but we have not…

  • News

    PSOGI/EURACAN Clinical Practice Guidelines

    A new consensus paper undertaking a complex and thorough investigation into current clinical practice has been released by an international group including many members of EuroPMP. As pseudomyxoma peritonei (PMP) is such a rare disease, it is difficult to find large, randomised trials on which to base treatment decisions. Therefore, using the Delphi consensus model, the Peritoneal Surface Oncology Group International (PSOGI) Executive Committe, which includes may members of EuroPMP, have examined and recommended a new and current best practice for the diagnosis and treatment of PMP. The Delphi decision model was used in conjunction with a broad literature review to come to this agreement, which will now form a…

  • News

    COST Advisory – COVID-19 Outbreak (updated)

    Updated 22 April 2020 at 19:00 (Originally published on 2nd February 2020 at 11:23am) New Information The COST Association has now asked that all face-to-face meetings, STSMs and training schools be cancelled until at least the 30th of April. The use of videoconferencing and other means of communication are recommended. The COST notice may be viewed here.   Previous Information The COST Association has released an advisory note about international travel in the context of the current coronavirus (COVID-19) outbreak. COST has examined the advice of the World Health Organisation (WHO) and national governmental bodies, and has determined that, for the present, international travel does not need to be limited…

  • News

    Twenty-Three Countries Now Acting on PMP

    Since the beginning of the EuroPMP COST Action about 1.5 years ago, the Action has included researchers from many countries, not just in Europe, but around the world. The number of countries now taking part in the action has doubled in the past year alone, and now includes partners from over 23 countries including  Azerbaijan, Bosnia and Herzegovina, Belgium, Germany, Greece, Spain, Finland, France, Croatia, North Macedonia, Ireland, Israel, Italy, Latvia, Montenegro, Norway, Pakistan, Poland, Portugal, Romania, Sweden, Turkey and the United Kingdom. The EuroPMP COST Action aims to increase cooperation between researchers across Europe and around the world to improve research into the cause, detection and treatment of Pseudomyxoma…

  • News

    NORD ACPMP Award for Flatmark Lab

    Prof Kjersti Flatmark’s research group in Oslo have been awarded a NORD ACPMP Research Grant (ID: 19010) to look into the identification of biomarkers in the blood stream of patients. The title of the study is “ctDNA for monitoring patients with pseudomyxoma peritonei”. Pseudomyxoma peritonei (PMP) is a rare abdominal cancer that exhibits specific DNA mutations. After treatment by surgery and intraperitoneal chemotherapy, radiological follow-up has low sensitivity and specificity for detecting disease recurrence. Mutations may be detectible in blood samples, and in this project we will establish and test a method for analyzing circulating tumor DNA (ctDNA) from patients with PMP before and after surgery. If successful, this method…

  • News

    New STSM to Oslo

    Yaroslaw Sautkin, a EuroPMP member from Germany, has completed a Short-Term Scientific Mission to Professor Kjersti Flatmark’s Translational Cancer Therapy lab at Oslo University Hospital’s Institute for Cancer Research. While on his STSM, Yaroslaw learned more about the use of experimental animal models for pseudomyxoma peritonei (PMP) in order to further the work that his own institution, the University of Tübingen, is undertaking into the use of PIPAC with mucolytic substances. Yaroslaw’s visit allowed members of both teams to meet and share knowledge, leading to stronger synergies between their researchers. Both groups are now looking forward to working on research projects together in the future. STSMs are offered several times…

  • News

    STSM Call for Applications – Spring 2020

    Short Term Scientific Missions (STSM) are exchange visits between researchers involved in a COST Action, allowing scientists to visit an institution or laboratory in another COST Member state. STSMs are institutional visits aimed at supporting individual mobility, fostering collaboration between individuals. These scientific missions may last from 5 days to up to 6 months. Their aim is to promote collaboration in excellent research infrastructures and share new techniques that may not be available in a participant’s home institution or laboratory. The deadline for the call is 29 February 2020. The STSM itself must take place prior to the end of April 2020. For more information about applying for an STSM,…

  • News

    EuroPMP ECI Workshop in Cordoba

      The EuroPMP COST Action held a workshop for its Early Career Investigator members in Cordoba on Friday, 4th October. In attendance were members from across Europe, including Spain, Italy, Norway, the United Kingdom, Germany and France. Many interesting talks were given on subjects ranging from the diagnosis and treatment of PMP to novel research going on in the field. Session 1 saw talks by Dr Norman Carr (UK) and Dr Martin (Spain) around the pathology and radiology of PMP. Much work is ongoing around diagnostic techniques and classifications, including the standardisation of methods in these two diverse fields. Dr Andrew Thrower (UK) gave an informative presentation on the evaluation…